Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Immunoprecise Antibodies Ltd (IPA)

Immunoprecise Antibodies Ltd (IPA)
0.4018 x 9 0.4200 x 10
Post-market by (Cboe BZX)
0.4071 -0.0308 (-7.03%) 04/21/25 [NASDAQ]
0.4018 x 9 0.4200 x 10
Post-market 0.4150 +0.0079 (+1.94%) 18:45 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.4009
Day High
0.4400
Open 0.4400
Previous Close 0.4379 0.4379
Volume 743,900 743,900
Avg Vol 493,955 493,955
Stochastic %K 67.31% 67.31%
Weighted Alpha -64.35 -64.35
5-Day Change -0.0242 (-5.61%) -0.0242 (-5.61%)
52-Week Range 0.2700 - 1.3900 0.2700 - 1.3900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,602
  • Shares Outstanding, K 31,062
  • Annual Sales, $ 18,160 K
  • Annual Income, $ -20,130 K
  • EBIT $ -9 M
  • EBITDA $ -4 M
  • 60-Month Beta -0.02
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book 0.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.76
  • Most Recent Earnings $-0.06 on 03/28/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 168.41% ( -89.35%)
  • Historical Volatility 105.88%
  • IV Percentile 18%
  • IV Rank 6.86%
  • IV High 1,166.58% on 03/11/25
  • IV Low 94.94% on 05/08/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 11
  • Volume Avg (30-Day) 64
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 4,249
  • Open Int (30-Day) 4,080

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/25
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.52
  • Growth Rate Est. (year over year) +96.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3161 +28.79%
on 03/31/25
Period Open: 0.4232
0.4790 -15.01%
on 04/15/25
-0.0161 (-3.80%)
since 03/21/25
3-Month
0.2700 +50.78%
on 03/04/25
Period Open: 0.4930
0.9244 -55.96%
on 01/22/25
-0.0859 (-17.42%)
since 01/21/25
52-Week
0.2700 +50.78%
on 03/04/25
Period Open: 1.2600
1.3900 -70.71%
on 04/29/24
-0.8529 (-67.69%)
since 04/19/24

Most Recent Stories

More News
IPA to Present at The Microcap Conference 2025

VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is...

IPA : 0.4071 (-7.03%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

THAR : 1.1500 (+1.78%)
ACXP : 0.3690 (-1.02%)
UBI.AX : 0.061 (-1.61%)
GRF.VN : 0.470 (unch)
WISA : 1.2100 (-6.92%)
NNVC : 1.3000 (-2.26%)
ALCO : 28.83 (-2.11%)
MYPS : 1.2600 (-1.56%)
ABL : 8.06 (-1.10%)
PERF : 1.6100 (unch)
PETV : 0.5199 (-6.44%)
ABEO : 4.92 (+1.65%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

ESGH.TO : 28.34 (+1.61%)
THAR : 1.1500 (+1.78%)
ACXP : 0.3690 (-1.02%)
GRF.VN : 0.470 (unch)
WISA : 1.2100 (-6.92%)
ALCO : 28.83 (-2.11%)
NNVC : 1.3000 (-2.26%)
ABL : 8.06 (-1.10%)
MYPS : 1.2600 (-1.56%)
PERF : 1.6100 (unch)
PETV : 0.5199 (-6.44%)
ABEO : 4.92 (+1.65%)
Light Week for Macroeconomic Figures in U.S.

Monday U.S. Economic Lookahead Consumer Credit (May) Featured Earnings Greenbrier ...

AZZ : 77.62 (-4.17%)
WDFC : 219.85 (-1.31%)
C : 62.69 (-0.89%)
JPM : 228.99 (-1.28%)
PRGS : 54.83 (-2.09%)
AMX : 16.18 (+0.31%)
PSMT : 93.76 (+0.13%)
SGH : 20.85 (+0.43%)
HELE : 31.89 (-5.34%)
PEP : 141.73 (-0.78%)
IPA : 0.4071 (-7.03%)
GBX : 41.77 (-2.54%)
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”) an AI-driven biotherapeutic research and technology company today announced a research collaboration...

IPA : 0.4071 (-7.03%)
European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), the parent company of BioKey and affiliate of BioStrand, announced today that the EPO has issued a “Decision...

IPA : 0.4071 (-7.03%)
ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, is pleased to announce that its wholly...

IPA : 0.4071 (-7.03%)
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for third quarter fiscal...

IPA : 0.4071 (-7.03%)
ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, today announced that Talem Therapeutics...

IPA : 0.4071 (-7.03%)
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss...

IPA : 0.4071 (-7.03%)

Business Summary

ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.

See More

Key Turning Points

3rd Resistance Point 0.4702
2nd Resistance Point 0.4551
1st Resistance Point 0.4311
Last Price 0.4071
1st Support Level 0.3920
2nd Support Level 0.3769
3rd Support Level 0.3529

See More

52-Week High 1.3900
Fibonacci 61.8% 0.9622
Fibonacci 50% 0.8300
Fibonacci 38.2% 0.6978
Last Price 0.4071
52-Week Low 0.2700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro